BioCentury
ARTICLE | Clinical News

PeramiFlu peramivir regulatory update

August 23, 2010 7:00 AM UTC

BioCryst said partner Green Cross received South Korean marketing approval for IV PeramiFlu peramivir to treat influenza A & B viruses, including pandemic H1N1 and avian flu. Green Cross, which has So...